Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Hepatitis C

Free Subscription Articles published in Scand J Gastroenterol Retrieve available abstracts of 13 articles: HTML format Text format

Single Articles

June 2018
1. MILLBOURN C, Psaros Einberg A, Lindh G, Hokeberg I, et al
   Prevalence and outcome of post-transfusion hepatitis C acquired at different ages and detected in look-back screening.
   Scand J Gastroenterol. 2018 Jun 18:1-6. doi: 10.1080/00365521.2018.1476911.
   PubMed     Text format     Abstract available
   
   
   May 2018
2. CARVALHO JR, Velosa J, Serejo F
   Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication - comparison of the new direct-acting antiviral agents with the old regimens.
   Scand J Gastroenterol. 2018 May 20:1-7. doi: 10.1080/00365521.2018.1473486.
   PubMed     Text format     Abstract available
   
   
   
3. SOLUND C, Hallager S, Pedersen MS, Fahnoe U, et al
   Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation.
   Scand J Gastroenterol. 2018 May 2:1-8. doi: 10.1080/00365521.2018.1467963.
   PubMed     Text format     Abstract available
   
   
   October 2017
4. HANSEN JF, Juul Nielsen M, Nystrom K, Leeming DJ, et al
   PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C.
   Scand J Gastroenterol. 2017 Oct 25:1-5. doi: 10.1080/00365521.2017.1392596.
   PubMed     Text format     Abstract available
   
   
   July 2017
5. 
   Correction to: Castedal et al., IFN-free sofosbuvir-based treatment of post-transplant hepatitis C relapse - a Swedish real life experience.
   Scand J Gastroenterol. 2017 Jul 13:1. doi: 10.1080/00365521.2017.1354499.
   PubMed     Text format    
   
   
   May 2017
6. MARIA C, Michael S, Susanne C, Catarina S, et al
   INF-free sofosbuvir-based treatment of post-transplant hepatitis C relapse - a Swedish real life experience.
   Scand J Gastroenterol. 2017;52:585-588.
   PubMed     Text format     Abstract available
   
   
   October 2016
7. ZHU H, Wu J, Shen X
   Genome-wide association study: new genetic insights into HBV/HCV-related hepatocellular carcinoma genomes.
   Scand J Gastroenterol. 2016.
   PubMed     Text format     Abstract available
   
   
   September 2016
8. BUSCH K, Waldenstrom J, Lagging M, Aleman S, et al
   Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden.
   Scand J Gastroenterol. 2016.
   PubMed     Text format     Abstract available
   
   
   July 2016
9. HARTLING HJ, Ballegaard VC, Nielsen NS, Gaardbo JC, et al
   Immune regulation in chronic hepatitis C virus infection.
   Scand J Gastroenterol. 2016.
   PubMed     Text format     Abstract available
   
   
   
10. MURUNGA E, Andersson M, Rensburg Cv
    Autoimmune hepatitis: a manifestation of immune reconstitution inflammatory syndrome in HIV infected patients?
    Scand J Gastroenterol. 2016;51:814-8.
    PubMed     Text format     Abstract available
    
    
    March 2016
11. LIM TS, Kim do Y, Han KH, Kim HS, et al
    Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Scand J Gastroenterol. 2016;51:344-53.
    PubMed     Text format     Abstract available
    
    
    September 2015
12. WALDENSTROM J, Farkkila M, Rembeck K, Norkrans G, et al
    Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience.
    Scand J Gastroenterol. 2015.
    PubMed     Text format     Abstract available
    
    
    May 2015
13. DZWONEK AB, Wozniakowska-GEsicka T, Wisniewska-Ligier M
    Mannose-binding lectin in chronic hepatitis C in children.
    Scand J Gastroenterol. 2015.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: